$SLNO
SOLENO THERAPEUTICS INC

2016 Q1 Form 10-Q Financial Statement

#000162828016016286 Filed on May 12, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $447.0K $22.00K
YoY Change 1931.82%
Cost Of Revenue $461.0K $18.00K
YoY Change 2461.11%
Gross Profit -$14.00K $4.000K
YoY Change -450.0%
Gross Profit Margin -3.13% 18.18%
Selling, General & Admin $2.477M $1.552M
YoY Change 59.6% 400.65%
% of Gross Profit 38800.0%
Research & Development $1.772M $878.0K
YoY Change 101.82% 136.02%
% of Gross Profit 21950.0%
Depreciation & Amortization $20.00K $20.00K
YoY Change 0.0% 100.0%
% of Gross Profit 500.0%
Operating Expenses $4.249M $2.430M
YoY Change 74.86% 255.26%
Operating Profit -$4.263M -$2.426M
YoY Change 75.72% 254.68%
Interest Expense $0.00 $1.000K
YoY Change -100.0% -99.74%
% of Operating Profit
Other Income/Expense, Net $1.074M -$9.225M
YoY Change -111.64% 115212.5%
Pretax Income -$1.970M -$11.65M
YoY Change -83.09% 1303.61%
Income Tax
% Of Pretax Income
Net Earnings -$3.189M -$11.65M
YoY Change -72.63% 1297.0%
Net Earnings / Revenue -713.42% -52959.09%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.039M -$8.381M
COMMON SHARES
Basic Shares Outstanding 15.40M shares 6.769M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.490M $9.530M
YoY Change -31.9% 1153.95%
Cash & Equivalents $6.492M $9.529M
Short-Term Investments
Other Short-Term Assets $260.0K $280.0K
YoY Change -7.14% 55.56%
Inventory $653.0K $206.0K
Prepaid Expenses
Receivables $187.0K $8.000K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.583M $10.02M
YoY Change -24.34% 912.42%
LONG-TERM ASSETS
Property, Plant & Equipment $121.0K $44.00K
YoY Change 175.0% 10.0%
Goodwill $718.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $76.00K
YoY Change
Total Long-Term Assets $1.807M $44.00K
YoY Change 4006.82% 10.0%
TOTAL ASSETS
Total Short-Term Assets $7.583M $10.02M
Total Long-Term Assets $1.807M $44.00K
Total Assets $9.390M $10.07M
YoY Change -6.72% 877.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.262M $621.0K
YoY Change 103.22% 590.0%
Accrued Expenses $1.320M $440.0K
YoY Change 200.0% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.579M $1.059M
YoY Change 143.53% -92.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $20.31M
YoY Change -99.02% 1564.75%
Total Long-Term Liabilities $200.0K $20.31M
YoY Change -99.02% 1564.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.579M $1.059M
Total Long-Term Liabilities $200.0K $20.31M
Total Liabilities $2.779M $21.37M
YoY Change -87.0% 34.32%
SHAREHOLDERS EQUITY
Retained Earnings -$89.44M -$81.99M
YoY Change 9.08%
Common Stock $95.27M $70.69M
YoY Change 34.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.834M -$11.30M
YoY Change
Total Liabilities & Shareholders Equity $9.390M $10.07M
YoY Change -6.72% 877.38%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$3.189M -$11.65M
YoY Change -72.63% 1297.0%
Depreciation, Depletion And Amortization $20.00K $20.00K
YoY Change 0.0% 100.0%
Cash From Operating Activities -$3.984M -$1.809M
YoY Change 120.23% 254.71%
INVESTING ACTIVITIES
Capital Expenditures $19.00K $1.000K
YoY Change 1800.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$19.00K -$1.000K
YoY Change 1800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $5.000M $3.382M
YoY Change 47.84%
NET CHANGE
Cash From Operating Activities -$3.984M -$1.809M
Cash From Investing Activities -$19.00K -$1.000K
Cash From Financing Activities $5.000M $3.382M
Net Change In Cash $997.0K $1.572M
YoY Change -36.58% -408.24%
FREE CASH FLOW
Cash From Operating Activities -$3.984M -$1.809M
Capital Expenditures $19.00K $1.000K
Free Cash Flow -$4.003M -$1.810M
YoY Change 121.16% 254.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 capn Additional Operating Lease Office Space
AdditionalOperatingLeaseOfficeSpace
5265 sqft
CY2016Q1 capn Classof Warrant Or Right Liquidated Damages Amount Percentof Volume Weighted Average Price
ClassofWarrantOrRightLiquidatedDamagesAmountPercentofVolumeWeightedAveragePrice
0.01
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
695000 USD
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1262000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
156000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
187000 USD
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1634000 USD
CY2016Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1317000 USD
CY2015Q1 capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
6174000 USD
CY2016Q1 capn Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-1170000 USD
CY2015Q1 capn Reduction In Initial Public Offering Costs Payable
ReductionInInitialPublicOfferingCostsPayable
45000 USD
CY2016Q1 capn Reduction In Initial Public Offering Costs Payable
ReductionInInitialPublicOfferingCostsPayable
0 USD
CY2015Q1 capn Transaction Costs Includedin Accrued Liabilities
TransactionCostsIncludedinAccruedLiabilities
131000 USD
CY2016Q1 capn Transaction Costs Includedin Accrued Liabilities
TransactionCostsIncludedinAccruedLiabilities
0 USD
CY2016Q1 capn Working Capital
WorkingCapital
5000000 USD
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001484565
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15461531 shares
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
Capnia, Inc.
CY2016Q1 dei Trading Symbol
TradingSymbol
CAPN
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
89456000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
95255000 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
401000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
136000 USD
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
8171 sqft
CY2015Q4 us-gaap Assets
Assets
8201000 USD
CY2016Q1 us-gaap Assets
Assets
9390000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
6404000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
7583000 USD
CY2015Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2016Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19000 USD
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7957000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9529000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5495000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6492000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1572000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
997000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14017909 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15403111 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14017909 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15403111 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
18000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
461000 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20000 USD
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.67
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000 USD
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6174000 USD
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1170000 USD
CY2015Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2016Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-94000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1292000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1939000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
718000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
718000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
4000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
-14000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
199000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
627000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
115000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-317000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
97000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
102000 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
72000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000 USD
CY2015Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
3050000 USD
CY2016Q1 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
1000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
0 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
46000 USD
CY2016Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
96000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
551000 USD
CY2016Q1 us-gaap Inventory Net
InventoryNet
653000 USD
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106000 USD
CY2016Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
290000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
399000 USD
CY2016Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
267000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8201000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9390000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3194000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2579000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3382000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1809000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3984000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-11651000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-3189000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
2430000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
4249000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2426000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4263000 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
62000 USD
CY2016Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
184000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000 USD
CY2015Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
917000 USD
CY2016Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
892000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
109000 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
200000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9225000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1074000 USD
CY2015Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
0 USD
CY2016Q1 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
2000 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
530000 USD
CY2016Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86247000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89436000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
22000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
447000 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
260000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14796119 shares
CY2016Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
538000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 USD
CY2015Q1 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
3050000 USD
CY2016Q1 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
167000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
216000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5071000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000 USD
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121000 USD
CY2015Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
102000 USD
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
878000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1772000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
35000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2016Q1 us-gaap Stock Issued1
StockIssued1
1665000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
3223000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
5834000 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6965483 shares
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">estimates. Key estimates included in the financial statements include the valuation of deferred income tax assets, liability and equity instruments, stock-based compensation, acquired intangibles, contingent earn-out consideration, and allowances for accounts receivable and inventory.</font></div></div>

Files In Submission

Name View Source Status
0001628280-16-016286-index-headers.html Edgar Link pending
0001628280-16-016286-index.html Edgar Link pending
0001628280-16-016286.txt Edgar Link pending
0001628280-16-016286-xbrl.zip Edgar Link pending
capn-20160331.xml Edgar Link completed
capn-20160331.xsd Edgar Link pending
capn-20160331x10q.htm Edgar Link pending
capn-20160331_cal.xml Edgar Link unprocessable
capn-20160331_def.xml Edgar Link unprocessable
capn-20160331_lab.xml Edgar Link unprocessable
capn-20160331_pre.xml Edgar Link unprocessable
ex-311.htm Edgar Link pending
ex-312.htm Edgar Link pending
ex-321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending